Takeda’s generic business is acquired by Sun Pharma subsidiary


Hannah Blake


Sun Pharmaceuticals has announced that its wholly-owned subsidiary, Caraco Pharmaceutical Laboratories, has entered into a definitive agreement with Takeda Pharmaceuticals to buy its URL Pharma generic business.

Japanese drug maker, Takeda, acquired URL Pharma, a formerly privately-held Philadelphia-based pharmaceutical company, in June 2012.

Upon completion of the purchase, the non-Colcrys (colchicine, USP) generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals.




Related news:

Sun Pharma arm to buy Takeda's US-based generics subsidiary URL Pharma (Economic Times)

Sun Pharma arm to buy generics business of US-based URL Pharma (Business Today)

Reference links:

Sun Pharma press release


profile mask


21 December, 2012